Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Assetz Exchange (AE) is a property crowdfunding platform that endeavours to break down barriers to investing in sustainable and under-supplied Buy-To-Let sectors so that investors can create a diversified property portfolio in minutes. AE argues that Buy-To-Let has hurdles, such as capital requirements, administration burden and transaction costs making it the least preferred option for average investors. It aims to change this scenario by converting properties into micro-units, allowing investors to invest as little or as much as they like, and taking care of administrative expenses. AE has launched 12 properties so far in 2020. It also concluded the purchase of four flats in a period conversion near Sefton Park in Liverpool in January 2020 for £600,000, with a plan to sell them on for £800,000. AE envisions to originate over £20 million worth of new properties in 2021. It will use the investment to expand its network of sourcing agents, build a larger credit team, invest in marketing campaigns, and increase automation wherever possible.
days to go:
Expired
investment:
£293,382
Warehouse home cater to urban living by specialising in the industrial home styling niche. They publish high end print and digital magazines bi-annually which feature styling tips and also real homes, and also have an online shop with carefully sourced designs for the ever growing industrial style home.
days to go:
Expired
investment:
£42,330
Vyomm is a property platform based in London for sellers, buyers and agents of Prime and Super Prime properties. Vyomm aims to become a preferred destination for Luxury, Exclusive, and Off Market Properties in London. Their engaging platform has gained substantial traction with several hundred Prime Central London properties. They have featured in Tatler, PrimeResi, Mirror and 12 other publications. With the investment, Vyomm plans to onboard top estate agents in London, expand into Asia, Europe and the USA, marketing and developmental operations.
days to go:
Expired
investment:
£178,280
Vesper Homes are a hybrid estate agents leading a rental revolution and aiming to save landlords and vendors an average of 50%. They are an expanding residential services company offering clients significantly lower fees and are looking to deploy a leading edge technology platform to improve services for both landlords and tenants.
days to go:
Expired
investment:
£121,371
Brickowner aims to become the leading service provider for property developers and asset managers, ensuring benefits for both parties. The company undertakes background checks of investors on its portal for the benefit of asset managers. It also ensures that investors can easily navigate its portal and find deals that suit their financial appetite. Brickowner successfully exited five investment rounds despite two investments happening in the wake of COVID-19. The platform has over 3,000 investors registered with over 700 active investors. It has overseen £14 million worth of investment on its portal to date. Brickowner will use the investment towards technology up-gradation, hire strategic personnel to expand marketing, and increase its marketing spend.
days to go:
Expired
investment:
£132,528
Brickowner is a service provider for property developers and asset managers wanting to improve the cost and efficiency of onboarding and managing investors. The company undertakes crucial tasks related to property transactions such as Anti Money Laundering (AML), Know Your Client (KYC), investor categorisation, and escrow requirements for its clients. These tasks take a lot of time and money through regular offline channels, but the company speeds up this process by taking it online. In 2017, a sum of £348,000 was invested through the company's platform which by January 2020 had reached over £12 million. The company has over 2400 investors registered on its platform wherein 630+ investors have invested in substantial investments. It has been featured in prominent publications such as Daily Mail, Property Week, London Evening Standard, and The Week. The company will use the investment aims to cover capital costs to support growth such as hiring, develop new technology to increase product availability, marketing strategy, and increase the technical capacity of the platform.
days to go:
Expired
investment:
£397,840
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
